Great point Maslow and something that is being WAY overlooked. Get Trof into and beyond Ph3 and out there for Retts then there's no stopping it's use across many of the Autism spectrum. Once the market wakes up to this and Big Pharma comes into play with the focus on that then we'll see blue sky prices.
- Forums
- ASX - By Stock
- Importance of the trial results & challenges
Great point Maslow and something that is being WAY overlooked....
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B |
Open | High | Low | Value | Volume |
$17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 598 | $16.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.87 | 1676 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 16.600 |
1 | 602 | 16.590 |
3 | 3054 | 16.500 |
1 | 89 | 16.450 |
1 | 609 | 16.400 |
Price($) | Vol. | No. |
---|---|---|
16.880 | 1600 | 2 |
16.980 | 1900 | 1 |
17.000 | 5000 | 1 |
17.080 | 1500 | 1 |
17.170 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online